Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up
Dave L Dixon,1 Leo F Buckley,1 Cory R Trankle,2 Dinesh Kadariya,3 Antonio Abbate2 1Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, 2Pauley Heart Center, 3Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA Abstract: Inhibit...
Saved in:
Main Authors: | Dixon DL (Author), Buckley LF (Author), Trankle CR (Author), Kadariya D (Author), Abbate A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of evolocumab and its potential in the treatment of hyperlipidemia
by: Cicero AF, et al.
Published: (2015) -
Retargeting the management of hypercholesterolemia – focus on evolocumab
by: Colletti A, et al.
Published: (2016) -
Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients
by: Huang CC, et al.
Published: (2019) -
Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review
by: Nashmil Ghadimi, et al.
Published: (2024) -
FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children
by: article Editorial
Published: (2021)